Dimitris Georgiadis

3.0k total citations
65 papers, 2.3k citations indexed

About

Dimitris Georgiadis is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Dimitris Georgiadis has authored 65 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 27 papers in Oncology and 24 papers in Organic Chemistry. Recurrent topics in Dimitris Georgiadis's work include Peptidase Inhibition and Analysis (27 papers), Chemical Synthesis and Analysis (22 papers) and Organophosphorus compounds synthesis (16 papers). Dimitris Georgiadis is often cited by papers focused on Peptidase Inhibition and Analysis (27 papers), Chemical Synthesis and Analysis (22 papers) and Organophosphorus compounds synthesis (16 papers). Dimitris Georgiadis collaborates with scholars based in Greece, France and United States. Dimitris Georgiadis's co-authors include Vincent Dive, Athanasios Yiotakis, Fabrice Beau, Magdalini Matziari, Efstratios Stratikos, Anastasios Makaritis, Bertrand Czarny, Laurent Devel, Anastasia Mpakali and Athanasios Papakyriakou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Dimitris Georgiadis

63 papers receiving 2.3k citations

Peers

Countries citing papers authored by Dimitris Georgiadis

Since Specialization

Citations

This map shows the geographic impact of Dimitris Georgiadis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitris Georgiadis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitris Georgiadis more than expected).

Fields of papers citing papers by Dimitris Georgiadis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitris Georgiadis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitris Georgiadis. The network helps show where Dimitris Georgiadis may publish in the future.

Co-authorship network of co-authors of Dimitris Georgiadis

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitris Georgiadis. A scholar is included among the top collaborators of Dimitris Georgiadis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitris Georgiadis. Dimitris Georgiadis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted approach to determine the impact of cancer-associated protease variants 2025 ·Science Advances ·(unknown), (unknown), Tomas Koudelka, (unknown), Franka Scharfenberg, (unknown), (unknown), Dimitris Georgiadis, Fabrice Beau, (unknown), Sascha Rahn, Andreas Tholey, Claus U. Pietrzik, Christoph Becker‐Pauly	1
2	Discovery of the First‐in‐Class Inhibitors of Hypoxia Up‐Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation 2024 ·Angewandte Chemie International Edition ·(unknown), (unknown), (unknown), (unknown), Martina Samiotaki, Konstantinos D. Papavasileiou, Antreas Afantitis, Niki Karagianni, Maria C. Denis, Julie Sanchez, (unknown), Z. Faidon Brotzakis, Γεώργιος Σκρέτας, Dimitris Georgiadis, Alexios N. Matralis, George Kollias	2
3	Ligand‐Directed Modification of Active Matrix Metalloproteases: Activity‐based Probes with no Photolabile Group 2021 ·Angewandte Chemie International Edition ·M. Kamińska, (unknown), Carole Malgorn, (unknown), (unknown), Carole Fruchart‐Gaillard, (unknown), Fabrice Beau, Robert Thaï, Isabelle Correia, Andrzej Gałat, Dimitris Georgiadis, Olivier Lequin, Vincent Dive, Sarah Bregant, Laurent Devel	14
4	Ligand‐Directed Modification of Active Matrix Metalloproteases: Activity‐based Probes with no Photolabile Group 2021 ·Angewandte Chemie ·M. Kamińska, (unknown), Carole Malgorn, (unknown), (unknown), Carole Fruchart‐Gaillard, (unknown), Fabrice Beau, Robert Thaï, Isabelle Correia, Andrzej Gałat, Dimitris Georgiadis, Olivier Lequin, Vincent Dive, Sarah Bregant, Laurent Devel	1
5	Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism 2021 ·Nature Communications ·(unknown), (unknown), Dimitris Georgiadis, Efstratios Stratikos, Lawrence J. Stern	24
6	The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I 2021 ·Scientific Reports ·(unknown), Anastasia Mpakali, Jérôme Zoidakis, Manousos Makridakis, Antonia Vlahou, (unknown), (unknown), Dimitris Georgiadis, Athanasios Papakyriakou, Efstratios Stratikos	5
7	A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1 2020 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), Jérôme Zoidakis, Manousos Makridakis, Antonia Vlahou, Anastasia Mpakali, (unknown), Dimitris Georgiadis, Robert Tampé, Athanasios Papakyriakou, Lawrence J. Stern, Efstratios Stratikos	15
8	The Discovery of Insulin-Regulated Aminopeptidase (IRAP) Inhibitors: A Literature Review 2020 ·Frontiers in Pharmacology ·Dimitris Georgiadis, (unknown), (unknown), (unknown), (unknown)	24
9	Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1) 2019 ·Cancer Immunology Immunotherapy ·Despoina Koumantou, Eilon Barnea, Adrian Martín‐Esteban, (unknown), Athanasios Papakyriakou, Anastasia Mpakali, Paraskevi Kokkala, Harris Pratsinis, Dimitris Georgiadis, Lawrence J. Stern, Arie Admon, Efstratios Stratikos	34
10	Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging 2019 ·Journal of Medicinal Chemistry ·Jakub Toczek, (unknown), Kiran Gona, Hye-Yeong Kim, Fabrice Beau, Dimitris Georgiadis, Isabelle Correia, Yunpeng Ye, Mahmoud Razavian, Jaejoon Jung, Olivier Lequin, Vincent Dive, Mehran M. Sadeghi, Laurent Devel	13
11	Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis 2015 ·Annals of the Rheumatic Diseases ·Liye Chen, Anna Ridley, Ariane Hammitzsch, Hussein Al‐Mossawi, (unknown), Dimitris Georgiadis, Antoni Chan, Simon Kollnberger, Paul Bowness	72
12	Autoimmune Disease-Associated Variants of Extracellular Endoplasmic Reticulum Aminopeptidase 1 Induce Altered Innate Immune Responses by Human Immune Cells 2015 ·Journal of Innate Immunity ·Yasser A. Aldhamen, (unknown), David P. W. Rastall, Sergey S. Seregin, Efthalia Zervoudi, Despoina Koumantou, Charles F. Aylsworth, Dionisia Quiroga, Sarah Godbehere, Dimitris Georgiadis, Efstratios Stratikos, Andrea Amalfitano	41
13	Phosphinic Peptides as Potent Inhibitors of Zinc-Metalloproteases 2014 ·Topics in current chemistry ·Dimitris Georgiadis, Vincent Dive	36
14	A Common Single Nucleotide Polymorphism in Endoplasmic Reticulum Aminopeptidase 2 Induces a Specificity Switch That Leads to Altered Antigen Processing 2012 ·The Journal of Immunology ·Irini Evnouchidou, James R. Birtley, Sergey S. Seregin, Athanasios Papakyriakou, Efthalia Zervoudi, Martina Samiotaki, George Panayotou, Petros Giastas, (unknown), Dimitris Georgiadis, Andrea Amalfitano, Emmanuel Saridakis, Irene M. Mavridis, Efstratios Stratikos	90
15	Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1′ cavity 2010 ·Biochimie ·Laurent Devel, Bertrand Czarny, Fabrice Beau, Dimitris Georgiadis, E.A. Stura, Vincent Dive	75
16	High-Resolution Crystal Structures of Drosophila melanogaster Angiotensin-Converting Enzyme in Complex with Novel Inhibitors and Antihypertensive Drugs 2010 ·Journal of Molecular Biology ·Mohd Akif, Dimitris Georgiadis, Aman Mahajan, Vincent Dive, Edward D. Sturrock, R. Elwyn Isaac, K. Ravi Acharya	68
17	Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild‐type angiotensin‐converting enzyme 2006 ·FEBS Journal ·Nicolas Jullien, Philippe Cuniasse, Dimitris Georgiadis, Athanasios Yiotakis, Vincent Dive	14
18	Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs 2004 ·Biochimie ·Philippe Cuniasse, Laurent Devel, Anastasios Makaritis, Fabrice Beau, Dimitris Georgiadis, Magdalini Matziari, Athanasios Yiotakis, Vincent Dive	103
19	Diastereoselective Solution and Multipin‐Based Combinatorial Array Synthesis of a Novel Class of Potent Phosphinic Metalloprotease Inhibitors 2003 ·Chemistry - A European Journal ·Anastasios Makaritis, Dimitris Georgiadis, (unknown), Athanasios Yiotakis	59
20	Synthesis and Comparative Study on the Reactivity of Peptidyl-Type Phosphinic Esters: Intramolecular Effects in the Alkaline and Acidic Cleavage of Methyl β-Carboxyphosphinates 2001 ·The Journal of Organic Chemistry ·Dimitris Georgiadis, Vincent Dive, Athanasios Yiotakis	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact